Eric Santoni Rugiu
Clinical Associate Professor
ORCID: 0000-0002-2283-3535
1 - 2 out of 2Page size: 10
- 2022
- Published
Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer
Urbanska, E. M., Sørensen, Jens Benn, Melchior, L. C., Costa, J. C. & Santoni Rugiu, Eric, 2022, In: JCO Precision Oncology. 6, 6, 6 p., e2200040.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Lost in digitization – A systematic review about the diagnostic test accuracy of digital pathology solutions
Kusta, Olsi, Rift, Charlotte Vestrup, Risør, Torsten, Santoni Rugiu, Eric & Brodersen, John Brandt, 2022, In: Journal of Pathology Informatics. 13, 11 p., 100136.Research output: Contribution to journal › Review › Research › peer-review
ID: 10801856
Most downloads
-
2950
downloads
Loss of miR-10a activates Lpo and collaborates with activated Wnt signaling in inducing intestinal Neoplasia in female mice
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
275
downloads
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1–Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
169
downloads
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Research output: Contribution to journal › Journal article › Research › peer-review
Published